PP26 Efficacy of HPV vaccines: a review of the evidence used by the WHO S Scharer1,2, AM Pollock1, P Sevcikova1 + Author Affiliations 1Centre for Primary Care and Public Health, Queen Mary University of London, London, UK 2Institute of General Practice, Family Medicine and Preventive Medicine, Paracelsus Medical University, Salzburg, Austria Abstract Background In 2009 the World Health […]
High prevalence of hpv multiple genotypes in women with persistent chlamydia trachomatis infection
Silva Seraceni1†, Francesco De Seta12, Claudia Colli3, Rossella Del Savio1, Giuliano Pesel1, Valentina Zanin1, Pierlanfranco D’Agaro12,Carlo Contini4 and Manola Comar12*† Abstract Background Chlamydia trachomatis interaction with HR-HPV types has highlighted a central role in cervical cancer development. The aim of this study was to investigate HPV prevalence and genotypes distribution in women at risk for […]
Anti HPV antibodies Levels among vaccinated and non-vaccinated Ugandan Girls
The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years Miriam Nakalembe1*, Cecily Banura2, Proscovia B Namujju34 and Florence M Mirembe1 Abstract Background Data on Human Papilloma virus (HPV) vaccine immune response in sub-Saharan Africa is still sparse yet such knowledge is critical for optimal implementation and monitoring […]
Monitoring Impact of a National HPV Vaccination Program in Japan (MINT Study): Rationale, Design and Methods
Monitoring Impact of a National HPV Vaccination Program in Japan (MINT Study): Rationale, Design and Methods Koji Matsumoto1,*, Nobuo Yaegashi2, Takashi Iwata3, Kazuya Ariyoshi4, Kiyoshi Fujiwara5, Yuko Shiroyama6, Tomoka Usami7, Yoshiaki Kawano8, Koji Horie9, Kouichiro Kawano10, Kiichiro Noda11 and Hiroyuki Yoshikawa1 for MINT Study Group Abstract We have developed a collaborative hospital-based approach to monitoring the impact of a human papillomavirus vaccine on cervical cancer, its precursor lesions […]
Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer
Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer Rafal S Sobota126*, Doreen Ramogola-Masire345, Scott M Williams2 andNicola M Zetola345* Abstract Background The worldwide administration of bivalent and quadrivalent HPV vaccines has resulted in cross-protection against non-vaccine HPV types. Infection with multiple HPV types may offer similar cross-protection […]
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 60
- Next Page »
